Discovery and pharmacological characterization of nanobodies acting as potent positive allosteric modulators of the calcium-sensing receptor — ASN Events
  1. Schedule
  2. CaSR-5 Session-3: CaS5 Signaling
  3. Discovery and pharmacological characterization of nanobodies acting as potent positive allosteric modulators of the calcium-sensing receptor

Discovery and pharmacological characterization of nanobodies acting as potent positive allosteric modulators of the calcium-sensing receptor (#162)

Jesper Mathiesen 1
  1. Zealand Pharma, Søborg, NA, Denmark

TBC**